13F Insight
DOSSIER · 13F Holders · Q4 2025
ERNA

Ernexa Therapeutics Inc

3 institutions still hold Ernexa Therapeutics Inc as of Q4 2025. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.

CUSIP 114082308·3 13F holders·last filed Dec 31, 2025
Market cap
—
13F value held
$23K
visible holders
Holders
3
filers reporting
Concentration
64.68%
HRT FINANCIAL LP #1
top holder share
AI Holders Summary · Q4 2025

3 institutions reported ERNA in Q4 2025. HRT FINANCIAL LP leads at 64.7% of the visible book.

Top holders

Sorted by position value. Source: SEC EDGAR 13F-HR filings.

#HolderValueShares% port.Quarter
01
HRT FINANCIAL LP
CIK 0001475597
$15K13K0.00%Q4 202502
JANE STREET GROUP, LLC
CIK 0001595888· Market maker
$8K41K0.00%Q1 202603
CONCOURSE FINANCIAL GROUP SECURITIES, INC.
CIK 0000752798
$00—Q2 2025
Insiders at Ernexa Therapeutics Inc
Cicala Peter →Bristol James Arthur →Luther Sanjeev →Ratner Elena →Wexler William A. →Polinsky David →Cherington Charles →Gurrola Sandra M →